US Stock Futures Flat; All Eyes On Fed Minutes

Pre-open movers US stock futures traded mostly flat in early pre-market trade. The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average dropped 5 points to 16,855.00, while the Standard & Poor's 500 index futures rose 0.30 points to 1,960.70. Futures for the Nasdaq 100 index gained 2 points to 3,865.25. A Peek Into Global Markets European markets were lower today, with the Spanish Ibex Index dropping 0.06%, STOXX Europe 600 Index declining 0.31%. German DAX 30 index fell 0.04%, French CAC 40 Index declined 0.07% and London's FTSE 100 Index dropped 0.56%. In Asian markets, Japan's Nikkei Stock Average fell 0.08%, Hong Kong's Hang Seng Index declined 1.55%, China's Shanghai Composite Index tumbled 1.23% and India's BSE Sensex dipped 0.54%. China's consumer price index rose 2.3% y/y in June, while the producer price index declined 1.1% y/y in June. Broker Recommendation Analysts at HSBC upgraded Schlumberger NV SLB from “neutral” to “overweight.” The target price for Schlumberger has been raised from $105 to $135. Schlumberger's shares closed at $116.75 yesterday. Breaking news

• Michael Kors KORS is pleased to announce that Mark Brashear has been named to the newly created role of President of Men's. To read the full news, click here.
• Lexicon Pharmaceuticals LXRX announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. To read the full news, click here.
• Boeing BA is enhancing its support to customers in Southeast Asia through a joint venture in Singapore with SIA Engineering Company SEGSF. To read the full news, click here.
• Ultragenyx Pharmaceutical RARE today announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. To read the full news, click here.